Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FKBP6 pseudogene 1 (FKBP6P1) is a **pseudogene** related to the FK506 binding protein 6 (FKBP6) gene family. Pseudogenes are nonfunctional segments of DNA resembling functional genes, often arising from gene duplication events or retrotransposition. FKBP6P1 does not encode a functional protein and is not associated with biological functions, disease roles, or drug targeting. It is not considered a therapeutic target, and there is no evidence linking it to any drug interactions, biomarker utility, or safety concerns. The correct biological target in this gene family would be FKBP6, not its pseudogene FKBP6P1[1][3]. **Note:** The term "FKBP6P1" specifically refers to a pseudogene as listed in genomic resources, and there is no evidence it encodes an active or druggable protein. Therefore, it is incorrect to treat FKBP6P1 as a pharmacological or therapeutic target[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FKBP6 pseudogene 1 (FKBP6P1).